Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 8.101\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) CCOc1ccc(-c2nn(-c3ccccc3)cc2/C=C2\SC(=S)N(C3CCS(=O)(=O)C3)C2=O)cc1
(b) O=C(Cc1c[nH]c2ccccc12)N1CCc2ccccc21
(c) COCCN(C(=O)C1CCN(C(=O)c2ccccc2C)CC1)c1c(N)n(CC(C)C)c(=O)[nH]c1=O
(d) N#Cc1c2ccccc2nc2ccccc12
(e) Cc1nn(-c2ccccn2)c2c1-c1nc(N3CCOCC3)ncc1CC2
Answer: e. Cc1nn(-c2ccccn2)c2c1-c1nc(N3CCOCC3)ncc1CC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(-c2ccccn2)c2c1-c1nc(N3CCOCC3)ncc1CC2
Cc1nn(-c2ccccn2)c2c1-c1nc(N3CCOCC3)ncc1CC2
4-(9-methyl-7-pyridin-2-yl-5,6-dihydropyrazolo[3,4-h]quinazolin-2-yl)morpholine